Home
Storia in 3 fonti
FDA approves Hepcludex for chronic hepatitis D
The FDA approved Hepcludex injection for the treatment of chronic hepatitis D infection in adults without cirrhosis or with compensated cirrhosis, according to a press release. Hepcludex (bulevirtide-gmod, Gilead Sciences) is the first FDA-approved treatment for the condition.
- ·
healio.com
FDA approves Hepcludex for chronic hepatitis D
The FDA approved Hepcludex injection for the treatment of chronic hepatitis D infection in adults without cirrhosis or with compensated cirrhosis, according to a press release.…
- ·
morningstar.com
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis…
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
- ·
endpoints.news
FDA clears Gilead's hepatitis D drug, four years after prior rejection
Gilead has at long last won US approval of its hepatitis D treatment Hepcludex, which the FDA previously rejected over issues with its manufacturing and distribution.